Document is current
Any future updates will be listed below
-
Authors
Zhou, Hanwen
Hu, Yue
Zheng, Yulong
Li, Jiefu
Peng, Jielong
Hu, Jiang
Yang, Yun
Chen, Wei
Zhang, Guoqing
Wang, Zefeng
-
Funding
Funding for this research was provided by:
Shanghai Science and Technology Innovation Action Plan (23JS1401500)
Shanghai Municipal Science and Technology Major Project (GTP)
National Key Research and Development Program of China (2021YFA1300503)
Strategic Priority Research Program of Chinese Academy of Sciences (XDB38040100)
National Natural Science Foundation of China (32030064)
BMGF-NSFC Joint Project on Vaccine Research and Development (W2412022)
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 20 August 2025
First Online: 24 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: Z.W. and Y.Y. has co-founded a company, CirCode Biotech, to commercialize the application of circular RNA as template of protein production/expression. They applied a patent in the optimization of IRES for circRNA translation. This does not prevent use or re-use of the method or output described in this paper. The other authors declare no competing interests.
